BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 31073154)

  • 1. Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs.
    Kundert K; Lucas JE; Watters KE; Fellmann C; Ng AH; Heineike BM; Fitzsimmons CM; Oakes BL; Qu J; Prasad N; Rosenberg OS; Savage DF; El-Samad H; Doudna JA; Kortemme T
    Nat Commun; 2019 May; 10(1):2127. PubMed ID: 31073154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Split-and-Click" sgRNA.
    Taemaitree L; Shivalingam A; El-Sagheer AH; Brown T
    Methods Mol Biol; 2021; 2162():61-78. PubMed ID: 32926378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guide RNA modification as a way to improve CRISPR/Cas9-based genome-editing systems.
    Filippova J; Matveeva A; Zhuravlev E; Stepanov G
    Biochimie; 2019 Dec; 167():49-60. PubMed ID: 31493470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Points of View on the Tools for Genome/Gene Editing.
    Chuang CK; Lin WM
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroporation-Based CRISPR/Cas9 Gene Editing Using Cas9 Protein and Chemically Modified sgRNAs.
    Laustsen A; Bak RO
    Methods Mol Biol; 2019; 1961():127-134. PubMed ID: 30912044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Assays for Comparing the Specificity of First- and Next-Generation CRISPR/Cas9 Systems.
    Cromwell CR; Hubbard BP
    Methods Mol Biol; 2021; 2162():215-232. PubMed ID: 32926385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of PDX-1 mutant porcine blastocysts by introducing CRISPR/Cas9-system into porcine zygotes via electroporation.
    Tanihara F; Hirata M; Nguyen NT; Le QA; Hirano T; Takemoto T; Nakai M; Fuchimoto DI; Otoi T
    Anim Sci J; 2019 Jan; 90(1):55-61. PubMed ID: 30368976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel White-to-Blue Colony Formation Assay to Select for Optimized sgRNAs.
    Wei C; Chen T; Zhang Y; Wang Y; Shi D; Jiang Z; Li K; Xiao L; Shen J
    Mol Biotechnol; 2021 Jan; 63(1):1-12. PubMed ID: 33047235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatch Intolerance of 5'-Truncated sgRNAs in CRISPR/Cas9 Enables Efficient Microbial Single-Base Genome Editing.
    Lee HJ; Kim HJ; Lee SJ
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Single Transcript CRISPR-Cas9 System for Multiplex Genome Editing in Plants.
    Tang X; Zhong Z; Ren Q; Liu B; Zhang Y
    Methods Mol Biol; 2019; 1917():75-82. PubMed ID: 30610629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Noncoding RNA Domains to Genomic Loci with CRISPR-Display: Guidelines for Designing, Building, and Testing sgRNA-ncRNA Expression Constructs.
    Shechner DM
    Methods Mol Biol; 2021; 2162():115-152. PubMed ID: 32926381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical and Functional Characterization of Differential CRISPR-Cas9 Ribonucleoprotein Complexes.
    Camperi J; Moshref M; Dai L; Lee HY
    Anal Chem; 2022 Jan; 94(2):1432-1440. PubMed ID: 34958212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector.
    Uranga M; Aragonés V; Selma S; Vázquez-Vilar M; Orzáez D; Daròs JA
    Plant J; 2021 Apr; 106(2):555-565. PubMed ID: 33484202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications.
    Labuhn M; Adams FF; Ng M; Knoess S; Schambach A; Charpentier EM; Schwarzer A; Mateo JL; Klusmann JH; Heckl D
    Nucleic Acids Res; 2018 Feb; 46(3):1375-1385. PubMed ID: 29267886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling the Activity of CRISPR Transcriptional Regulators with Inducible sgRNAs.
    Ferry QRV; Fulga TA
    Methods Mol Biol; 2021; 2162():153-184. PubMed ID: 32926382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A catalogue of biochemically diverse CRISPR-Cas9 orthologs.
    Gasiunas G; Young JK; Karvelis T; Kazlauskas D; Urbaitis T; Jasnauskaite M; Grusyte MM; Paulraj S; Wang PH; Hou Z; Dooley SK; Cigan M; Alarcon C; Chilcoat ND; Bigelyte G; Curcuru JL; Mabuchi M; Sun Z; Fuchs RT; Schildkraut E; Weigele PR; Jack WE; Robb GB; Venclovas Č; Siksnys V
    Nat Commun; 2020 Nov; 11(1):5512. PubMed ID: 33139742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High efficiency CRISPR/Cas9 genome editing system with an eliminable episomal sgRNA plasmid in Pichia pastoris.
    Yang Y; Liu G; Chen X; Liu M; Zhan C; Liu X; Bai Z
    Enzyme Microb Technol; 2020 Aug; 138():109556. PubMed ID: 32527526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 Guide RNA Design Rules for Predicting Activity.
    Hiranniramol K; Chen Y; Wang X
    Methods Mol Biol; 2020; 2115():351-364. PubMed ID: 32006410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.